Former FDA Commissioner Dr. Scott Gottlieb joins ‘Squawk Box’ to discuss the list of applications for new weight-loss drugs, how the weight-loss drugs can help neurocognitive conditions, and much more.
Ozempic, Wegovy trials show positive results for Dementia, alcohol addiction
Relevant and recent posts
Niall Ferguson: Real Estate-ism Got the Deal Done in Gaza
Trump’s critics pine for old-school diplomacy. But Jared Kushner and Steve Witkoff triumphed where Joe Biden’s national security professionals failed. It has been a tough…
Thought Leader: Niall Ferguson
Niall Ferguson: The Disrupter in Chief’s Global Impact
No president has ever delivered so much so quickly. But Trump’s biggest challenge lies ahead in Xi Jinping’s China. The U.S. Constitution defines the president…
Thought Leader: Niall Ferguson
Dr. Sanjay Gupta: Why It Costs So Much to Get Sick
Since the 1990s, healthcare has been at the heart of America’s political debate and it’s still being contested today. Why is our health system so complicated? And how can we fix it? To help demystify it,…
Thought Leader: Sanjay Gupta
More with this speaker
Scott Gottlieb on China’s biotech strategy
Thought Leader: Scott Gottlieb
Scott Gottlieb: China’s edge over U.S. biotech
Thought Leader: Scott Gottlieb